INVA FY 2023 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena

INVAInnoviva, Inc.

$1B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$310M-6.3% YoY

Gross Profit

$268M86.3% margin

Operating Income

$114M36.7% margin

Net Income

$180M57.9% margin

EPS (Diluted)

$2.20

Cash Flow

Operating Cash Flow

$141M

Free Cash Flow

$141M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$569M

Stockholders' Equity

$675M

Cash & Equivalents

$194M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$310M	$331M	-6.3%
Gross Profit	$268M	$318M	-15.7%
Operating Income	$114M	-$37M	+408.2%
Net Income	$180M	$214M	-16.0%